-
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating
01 Feb 2026 19:08 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) is among the 12 Most Profitable … Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to … heading into fourth-quarter earnings. The firm is also … also provided an update on Gilead Sciences, Inc. (NASDAQ:GILD). …
-
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
31 Jan 2026 20:30 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) is among the most profitable healthcare … lifted the price target on Gilead Sciences, Inc. (NASDAQ:GILD … also raised its target on Gilead Sciences, Inc. (NASDAQ:GILD … company’s HIV business. Gilead Sciences, Inc. (NASDAQ:GILD) …
-
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
04 Feb 2026 19:33 GMT
… 2024. Meanwhile, GSK’s core earnings per share (EPS), which excludes … 2025, Citi analysts expect that Gilead Sciences will continue to be the …
-
WACO Theater Center Announces Launch of Still Here Magazine, Centering Black Women Impacted by HIV
04 Feb 2026 16:38 GMT
… Center is a non-profit organization based in Los … ;wacotheatercenter.com/.
About Gilead Sciences: Gilead Sciences, Inc. is a biopharmaceutical company … X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
Thursday, February 12 …
-
Gilead Sciences exercises option to license Assembly Biosciences Helicase-Primase Inhibitor programs for recurrent genital herpes
28 Dec 2025 11:19 GMT
Foster City: Gilead Sciences and Assembly Biosciences have announced … Development, Virology Therapeutic Area Head, Gilead Sciences. “Collaborations and partnerships are key … 40% of all costs and profits in the United States in …
-
US close: Markets gain as financial earnings impress, chipmakers rise
16 Jan 2026 07:56 GMT
… and Morgan Stanley impress
Quarterly profits at Goldman Sachs comfortably … and bumper trading revenues. Diluted earnings per share rose to $ … topped both revenue and profit estimates on the back … (SWKS) $58.46 -2.34%
Gilead Sciences Inc. (GILD) $121.26 -2 …
-
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
04 Feb 2026 12:00 GMT
… the biotech industry in a profitable and diversified manner. Our business … including Amgen, Merck, Pfizer, Jazz, Gilead Sciences and Baxter International. For more …
-
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
22 Dec 2025 14:16 GMT
… 40% of all costs and profits in the United States in … from Gilead next year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company … potential effects on Gilead’s earnings; the ability of Gilead to …
-
DOJ’s False Claims Act Bread and Butter — The Healthcare Industry (Part II of II)
03 Feb 2026 23:51 GMT
… insurers perceived to be less profitable for them.
As to prescription … ingredients used in compound prescriptions.
Gilead Sciences, Inc. agreed to pay $176 …
-
A Glimpse of Gilead Sciences's Earnings Potential
29 Oct 2025 14:57 GMT
…
Revenue Growth
Gross Profit
Return on Equity
Gilead Sciences
Buy
1.84% … Profit. For Return on Equity, Gilead Sciences is at the bottom.
Delving into Gilead Sciences …
To track all earnings releases for Gilead Sciences visit their earnings calendar on our …
About
© 1995-2026